A study to compare the effects of two doses of oral drug isotretinoin in the treatment of pimples
Phase 4
- Conditions
- Health Condition 1: L700- Acne vulgaris
- Registration Number
- CTRI/2023/09/057402
- Lead Sponsor
- orth Eastern Indira Gandhi Regional Institute of Health and Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Patients aged 18 years and above and diagnosed with grade 2 acne vulgaris after clinical assessment who are isotretinoin naive and who have not responded to previous topical anti acne agents or oral antibiotics
Exclusion Criteria
1. Pregnant or lactating women
2. Deranged liver function
3. Deranged lipid profile
4. Concomitant oral antibiotics
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The primary outcome of the study will be the comparison of efficacy of low dose daily & intermittent dose oral isotretinoin regimens in patients of grade 2 acne vulgaris <br/ ><br>Timepoint: Assessment at 3 & 6 months
- Secondary Outcome Measures
Name Time Method The secondary outcome will be the comparision of side effect profile & patient satisfaction of the two regimensTimepoint: Assessment at 3 & 6 months